Arizona Bioscience News: Canadian firm’s acquisition; Offseason flu activity; UArizona pushes for international startups

June 23, 2022

By Jessica Vaile

Canadian health care company enters US market with Arizona acquisition / Phoenix Business Journal

Phoenix-based medical equipment supplier Comp-Ray, which has been providing medical imaging hardware and software for nearly 40 years, has been acquired by Montreal-based Christie Innomed.

UArizona innovation center pitches state to two Canadian startups Phoenix Business Journal (AZ Inno)

The University of Arizona’s Center for Innovation in Tucson is using its Global Advantage Soft Landings program to connect international startups with community leaders, government officials, and other resources in southern Arizona.

Trial of new Alzheimer’s drug reports disappointing results / New York Times

The drug, crenezumab, failed to prevent early symptoms or slow cognitive decline, the latest setback in the long quest to find effective therapies for Alzheimer’s disease.

Arizona flu activity remaining high despite being offseason / KJZZ

Last week, the Arizona Department of Health Services saw nearly 800 confirmed flu cases. At the same time last year, it only recorded 10.

What happens when Valley fever and COVID-19 collide? KJZZ

A Mayo Clinic consultant co-authored a paper after looking at more than 3,300 patients with Valley fever and nearly 6,000 with COVID-19, with 60 having both at roughly the same time. Read more: Banner Health: Monsoon increases Valley fever risk

Upcoming Events / 

July 18-21: Venom Week VIII (SkySong)

September 25-30: Arizona Bioscience Week

Search the Arizona BioMap